Indivior PLC (LON:INDV - Get Free Report) passed above its fifty day moving average during trading on Tuesday . The stock has a fifty day moving average of GBX 1,014.80 ($13.72) and traded as high as GBX 1,221 ($16.51). Indivior shares last traded at GBX 1,183 ($15.99), with a volume of 619,511 shares.
Indivior Stock Up 2.1%
The business has a fifty day simple moving average of GBX 1,014.80 and a 200 day simple moving average of GBX 879.02. The firm has a market cap of £1.89 billion, a price-to-earnings ratio of -1,001.61, a PEG ratio of -5.57 and a beta of 0.19. The company has a debt-to-equity ratio of -170.06, a current ratio of 0.83 and a quick ratio of 1.52.
Insider Activity at Indivior
In other Indivior news, insider Juliet Thompson acquired 1,925 shares of the stock in a transaction that occurred on Wednesday, June 11th. The stock was bought at an average cost of GBX 1,388 ($18.76) per share, for a total transaction of £26,719 ($36,121.40). Corporate insiders own 3.44% of the company's stock.
About Indivior
(
Get Free Report)
Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders in the United States, the United Kingdom, and internationally. The company develops medicines to treat substance use disorders, serious mental illnesses, and opioid overdose.
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Indivior, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Indivior wasn't on the list.
While Indivior currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
